(Q38117035)

29 August 2017

Exchange transfusion for severe malaria: evidence base and literature review (English)

1 reference

29 August 2017

0 references

3

Paul M Arguin

1 reference

29 August 2017

Kathrine R Tan

1

1 reference

PubMed ID

23800940

29 August 2017

Ryan E Wiegand

series ordinal

2

1 reference

PubMed ID

23800940

29 August 2017

language of work or name

English

0 references

publication date

24 June 2013

1 reference

Clinical Infectious Diseases

29 August 2017

1 reference

29 August 2017

57

1 reference

29 August 2017

923-928

1 reference

29 August 2017

7

1 reference

Human malarial disease: a consequence of inflammatory cytokine release

29 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Clinical application of therapeutic erythrocytapheresis (TEA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Treatment of malaria in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

[Fatal cerebral malaria caused by Plasmodium falciparum after treatment with exchange transfusion]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Therapeutic apheresis in Sweden: update of epidemiology and adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Plasma exchange in critically ill patients with sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Frequency of immediate adverse effects associated with therapeutic apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Automated erythrocytapheresis for severe falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

Artemisinin Resistance in Plasmodium falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT429

21 January 2018

Identifiers

DOI

10.1093/CID/CIT429

1 reference

29 August 2017

1 reference

PubMed ID

23800940